Huya Bioscience International Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Latest Deal Type
  • Debt - PPP

Huya Bioscience International General Information

Description

Operator of a bio-science company intended to accelerate biopharmaceutical innovation. The company identifies and licenses the most promising pre-clinical and clinical-stage compounds, then leverages and extends the research efforts of its partners and also provides a bridge into the international development process and global biopharma market while lowering risk, providing partner companies with an ensured and continuous source of compounds for the future.

Contact Information

Website
www.huyabio.com
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • 12531 High Bluff Drive
  • Suite 138
  • San Diego, CA 92130
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Huya Bioscience International Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Debt - PPP 03-May-2020 0000 Completed
3. Angel (individual) 22-Apr-2015 0000 0000 Completed Generating Revenue
2. Angel (individual) 27-Mar-2012 $7.61M $5M Completed Generating Revenue
1. Angel (individual) 07-Apr-2009 $5M $5M Completed Startup
To view Huya Bioscience International’s complete valuation and funding history, request access »

Huya Bioscience International Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a bio-science company intended to accelerate biopharmaceutical innovation. The company identifies and licens
Pharmaceuticals
San Diego, CA
0000
000000000 - 0000

00000000

aboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate
000000000000000
Dublin, Ireland
0000 As of 0000
00.000
000000000 00.000

000000 0

olor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
0000000000000
San Francisco, CA
000 As of 0000
00.000
000 0000-00-00
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Huya Bioscience International Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alkermes Formerly VC-backed Dublin, Ireland 0000 00.000 000000000 00.000
000000 00000000000 Formerly VC-backed San Francisco, CA 000 00.000 000000000 00.000
0000 000000 Private Debt Financed Monmouth Junction, NJ 000 000000000 -
00000000000 000000 Private Equity-Backed Mexico City, Mexico 000.00 0000000 0000
000000 00000000 Corporation Tokyo, Japan 00000 00.000 00000000 00.000
You’re viewing 5 of 9 competitors. Get the full list »

Huya Bioscience International Executive Team (9)

Name Title Board Seat Contact Info
Mireille Gillings Ph.D Founder, President, Chief Executive Officer and Executive Chairwoman
Arthur Cheng Chief Financial Officer
Clement Gingras Chief Technology Officer, Chief Operating Officer Asia & Board Member
Kenneth Polin Chief Administrative Officer & General Counsel
Tim Simon Chief Commercial Officer
You’re viewing 5 of 9 executive team members. Get the full list »

Huya Bioscience International Board Members (6)

Name Representing Role Since
Clement Gingras Huya Bioscience International Chief Technology Officer, Chief Operating Officer Asia & Board Member 000 0000
Derek Winstanly Huya Bioscience International Board Member 000 0000
Michael Mortimer Huya Bioscience International Board Member 000 0000
Michael Mortimer Self Board Member 000 0000
Mireille Gillings Ph.D Huya Bioscience International Founder, President, Chief Executive Officer and Executive Chairwoman 000 0000
You’re viewing 5 of 6 board members. Get the full list »